ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 163 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $46 | -20.7% | 2,140 | 0.0% | 0.00% | – |
| Q1 2024 | $58 | -77.6% | 2,140 | -75.3% | 0.00% | -100.0% |
| Q4 2023 | $259 | +54.2% | 8,653 | +5.4% | 0.00% | +100.0% |
| Q3 2023 | $168 | +3.1% | 8,213 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $163 | +64.6% | 8,213 | +42.1% | 0.00% | 0.0% |
| Q1 2023 | $99 | -28.3% | 5,779 | -18.2% | 0.00% | 0.0% |
| Q4 2022 | $138 | -99.8% | 7,064 | +27.0% | 0.00% | 0.0% |
| Q3 2022 | $89,000 | +15.6% | 5,561 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $77,000 | -27.4% | 5,561 | -17.1% | 0.00% | 0.0% |
| Q1 2022 | $106,000 | -50.9% | 6,711 | -7.3% | 0.00% | -50.0% |
| Q3 2021 | $216,000 | -34.9% | 7,238 | -3.5% | 0.00% | -33.3% |
| Q2 2021 | $332,000 | +40.7% | 7,502 | +40.9% | 0.00% | -66.7% |
| Q1 2021 | $236,000 | -19.2% | 5,323 | +0.0% | 0.01% | -18.2% |
| Q4 2020 | $292,000 | – | 5,322 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |